Taipei, Friday, August 28, 2015 23:20 (GMT+8)
light rain
Taipei
25°C
Apex sees increase in revenues, but drop in profits in 2013 - related company info
Patty Wang, Taipei; Joseph Tsai, DIGITIMES [Thursday 26 June 2014]
  • Apex Biotechnology
  • Performance
    The company's stock price closed at NT$36 on the TSE on Thursday, August 27, 2015.
    The company has reported consolidated revenues of NT$162 million for July 2015, representing a 16.7% increase on month and 0.8% drop on year.
    For the second quarter of 2015, the company totaled NT$423 million in consolidated revenues, down 10.9% sequentially and down 4.4% on year.
    Brief

    Full name: Apex Biotechnology

    Chinese name: 五鼎生物技術股份有限公司

    Short name: Apex

    Stock code: 1733

    Tax ID: 16130182

    Market: TSE

    Established: 2 Dec 1997

    Paid in capital: NT$985.31 million

    Listed on TSE: 17 Sep 2001

    Website: www.apexbio.com

  • Latest stock
    Apex [1733] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    28-Aug 124 109 4,497,473 36.00 36.50 36.00 36.20+0.20+0.56% 36.35 36.20
    27-Aug 191 159 6,634,049 33.50 36.50 33.50 36.00+2.65+7.95% 36.15 35.90
    26-Aug 138 107 4,546,044 33.00 33.35 32.50 33.35+0.35+1.06% 33.40 33.30
    25-Aug 257 202 8,260,365 33.00 33.00 31.50 33.00-0.25-0.75% 33.00 32.75
    24-Aug 426 319 14,227,617 34.00 35.00 33.25 33.25-3.65-9.89% 33.75 33.25
    21-Aug 125 113 4,692,734 38.90 38.90 36.80 36.90-2.00-5.14% 36.95 36.90
    20-Aug 75 66 2,923,450 39.10 39.15 38.80 38.90-0.20-0.51% 39.10 38.90
    19-Aug 93 87 3,701,531 40.35 40.45 39.00 39.10-1.25-3.10% 39.50 39.10
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Jul 2014 - Jul 2015 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Jul-15

    162

    16.7%

    (0.8%)

    1,059

    2.9%

    Jun-15

    139

    8.6%

    (10.1%)

    897

    3.7%

    May-15

    128

    (18.3%)

    (20.4%)

    758

    6.6%

    Apr-15

    156

    (14.2%)

    22.6%

    631

    14.5%

    Mar-15

    182

    36.4%

    31.7%

    474

    12.1%

    Feb-15

    134

    (15.8%)

    5.9%

    292

    2.5%

    Jan-15

    159

    (7.2%)

    (0.2%)

    159

    (0.2%)

    Dec-14

    171

    7%

    36.1%

    1,789

    (2.2%)

    Nov-14

    160

    (2.9%)

    39.7%

    1,618

    (5%)

    Oct-14

    165

    18.7%

    43.9%

    1,458

    (8.3%)

    Sep-14

    139

    9.9%

    (10.2%)

    1,294

    (12.3%)

    Aug-14

    126

    (22.7%)

    (18.1%)

    1,155

    (12.5%)

    Jul-14

    163

    5.8%

    11.9%

    1,029

    (11.8%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, August 2015

    Apex: Consolidated revenues, 2Q14 - 2Q15 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    2Q-15

    423

    (10.9%)

    (4.4%)

    897

    3.7%

    1Q-15

    474

    (4.3%)

    12.1%

    474

    12.1%

    4Q-14

    495

    15.7%

    39.8%

    1,789

    (2.2%)

    3Q-14

    428

    (3.2%)

    (5.8%)

    1,294

    (12.3%)

    2Q-14

    442

    4.5%

    (10.9%)

    865

    (15.2%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, August 2015

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 2Q14 - 2Q15 (NT$k)

    Item

    2Q-2015

    1Q-2015

    4Q-2014

    3Q-2014

    2Q-2014

    Current assets

    1,546,525

    1,513,288

    1,432,012

    1,443,777

    1,716,112

    Intangible assets

    28,756

    30,804

    30,521

    30,974

    26,283

    Non-current assets

    1,172,865

    1,194,194

    1,212,882

    1,239,343

    1,254,992

    Assets

    2,719,390

    2,707,482

    2,644,894

    2,683,120

    2,971,104

    Current liabilities

    997,962

    779,492

    752,294

    873,784

    829,041

    Non-current liabilities

    24,418

    25,322

    26,228

    27,365

    421,448

    Liabilities

    1,022,380

    804,814

    778,522

    901,149

    1,250,489

    Stockholders' equity

    1,697,010

    1,902,668

    1,866,372

    1,781,971

    1,720,615

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, August 2015

    Apex: Consolidated income statement, 2Q14 - 2Q15 (NT$k)

    Item

    2Q-2015

    1Q-2015

    4Q-2014

    3Q-2014

    2Q-2014

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

    0

     

     

     

     

     

     

     

    0

     

    Operating revenue

    422,810

     

    474,282

     

    495,347

     

    428,083

     

    442,277

     

    Gross profit (loss) from operations

    113,292

     

    120,840

     

    145,823

     

    126,088

     

    138,765

     

    Operating expenses

    59,501

     

    57,767

     

    70,142

     

    57,677

     

    53,267

     

    Operating income (loss)

    53,791

     

    63,073

     

    75,681

     

    68,411

     

    85,498

     

    Non-operating expenses and losses

    -5,762

     

    -19,875

     

    23,037

     

    6,053

     

    -11,980

     

    Income from continuing operations before income tax

    48,029

     

    43,198

     

    98,718

     

    74,464

     

    73,518

     

    Net income (loss)

    40,815

     

    36,704

     

    83,468

     

    60,904

     

    62,496

     

    Diluted earnings per share (NT$)

    0.4

     

    0.4

     

    0.8

     

    0.6

     

    0.6

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, August 2015

  • Apex Biotechnology full profile

27-Aug-2015 markets closed

 LastChange

TAIEX (TSE)7824.55+108.96+1.41% 

TSE electronic300.63+5.39+1.83% 

GTSM (OTC)105.56+2.40+2.33% 

OTC electronic133.75+3.46+2.66% 

Kromax
Trends and forecasts for the China FPD industry, 2014-2017
The transition to 4k TV - UHD TV market forecast, 2014-2017
  • Wireless broadband developments in Southeast Asia markets

    As of 2013, the 10 ASEAN nations had a total of over 700 million mobile subscriptions, with the CAGR from 2003-2013 reaching 24%. This Digitimes Research Special Report analyzes the various mobile broadband markets in ASEAN and looks at the respective trends in 4G LTE development for those markets.

  • 2015 global tablet demand forecast

    This Digitimes Research Special Report provides a 2015 forecast for the global tablet market and analyzes the strategies of key market players such as Google, Apple, Intel, and Microsoft.

  • 2015 China smartphone panel trend forecast

    This Digitimes Research Special Report analyzes the strategies of key China-based major panel makers BOE, Tianma and IVO for attacking the different market segments through technology and pricing, and their relationship to local vendors Huawei, Lenovo, ZTE, Xiaomi and Coolpad.